The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug.
The NIH Neuroscience Microarray Consortium today announced that it has added high-density genotyping on both the Affymetrix and Illumina platforms to its list of services. Stan Nelson, the principal investigator at UCLA, says that “adding ultra-high throughput genotyping for its user-base of approx. 10,000 investigators across the world keeps the consortium current with the demands of the scientific community.”
Soldiers exposed to the deafening din of battle have little defense against hearing loss, and are often reluctant to wear protective gear like ear plugs that could make them less able to react to danger. But what if a nutritious daily “candy bar” could prevent much of that potential damage to their hearing?
People are mixing supplements, herbs and over-the-counter medications and prescription drugs to cure themselves of ills, unaware that they could be making themselves sicker, says George Grossberg, M.D., director of the division of geriatric psychiatry at Saint Louis University.
One of the most common genetic defects passed on through families significantly increases a person’s chance of having a stroke, according to a study published in the March 27, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology.
New discoveries offer promise for developing drugs that improve on the therapeutic profile of niacin, the inexpensive, time-tested B-vitamin that boosts levels of HDL cholesterol ? the ?good? cholesterol with the potential to protect people against heart attacks and stroke, scientists reported today.
Clinical trial of new blood thinner shows promise of significantly reducing the risk of heart attack and death with no statistical increase in major and minor bleeding events.
Severe heart attacks are often treated with non-surgical procedures that open narrowed or blocked arteries of the heart using stents (percutaneous coronary intervention, or PCI).
High-risk surgical patients in community hospital settings can safely benefit from the use of new embolus-removing and stent-inserting systems, according to a study presented today at the American College of Cardiology?s Innovation in Intervention: i2 Summit in New Orleans, La.
Giving up smoking can reduce the risk of dying from the disease by up to 70 percent, new research published in the American Journal of Epidemiology this week shows.